Advertisement

Topics

HHS Nominee Azar: Great News For Industry But ACA Reform Will Be Priority

11:33 EST 13 Nov 2017 | SCRIP

Insurance practices are a big driver of drug pricing problems, according to Azar, a former Lilly exec who spent six...

      

Related Stories

 

Original Article: HHS Nominee Azar: Great News For Industry But ACA Reform Will Be Priority

NEXT ARTICLE

More From BioPortfolio on "HHS Nominee Azar: Great News For Industry But ACA Reform Will Be Priority"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Lilly
Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in over 50 countries with just under 40,000 employees. Appr...